AAAAAA

   
Results: 1-7 |
Results: 7
GRAFT-VERSUS-HOST DISEASE AND SURVIVAL IN GRADED INCREMENTAL ADD-BACK(GIAB) FOR T-CELL DEPLETION-ALLOGENEIC BONE-MARROW TRANSPLANTATION (TCD-AL-BMT), COMPARED TO 2-LEVEL ADD-BACK (TLAB)
Authors: LEE CK GINGRICH RD HARMAN GS HOHL RJ SVSEL IA FRANCY RJ AJRAM KA JOHANNSEN SM
Citation: Ck. Lee et al., GRAFT-VERSUS-HOST DISEASE AND SURVIVAL IN GRADED INCREMENTAL ADD-BACK(GIAB) FOR T-CELL DEPLETION-ALLOGENEIC BONE-MARROW TRANSPLANTATION (TCD-AL-BMT), COMPARED TO 2-LEVEL ADD-BACK (TLAB), Blood, 88(10), 1996, pp. 3777-3777
RISK FACTOR-DEPENDENT MODULATION OF GRAFT-VERSUS-HOST DISEASE (GVHD) BY GRADED INCREMENTAL T-CELL ADD-BACK (GIAB) IN T-CELL DEPLETION ALLOGENEIC BONE-MARROW TRANSPLANTATION (TCD-AL-BMT)
Authors: LEE CK GINGRICH RD HARMAN GS HOHL RJ SYSEL IA FRANCY RJ AJRAM KA JOHANNSEN SM
Citation: Ck. Lee et al., RISK FACTOR-DEPENDENT MODULATION OF GRAFT-VERSUS-HOST DISEASE (GVHD) BY GRADED INCREMENTAL T-CELL ADD-BACK (GIAB) IN T-CELL DEPLETION ALLOGENEIC BONE-MARROW TRANSPLANTATION (TCD-AL-BMT), Blood, 88(10), 1996, pp. 1662-1662
ENGRAFTMENT SYNDROME IN AUTOLOGOUS BONE-MARROW AND PERIPHERAL STEM-CELL TRANSPLANTATION
Authors: LEE CK GINGRICH RD HOHL RJ AJRAM KA
Citation: Ck. Lee et al., ENGRAFTMENT SYNDROME IN AUTOLOGOUS BONE-MARROW AND PERIPHERAL STEM-CELL TRANSPLANTATION, Bone marrow transplantation, 16(1), 1995, pp. 175-182
A PILOT-STUDY OF AUTOLOGOUS MARROW BLOOD STEM-CELL TRANSPLANTATION INTHE TREATMENT NONMETASTATIC INFLAMMATORY BREAST-CANCER/
Authors: GINGRICH RD LEE CK WEN BC HOHL RJ HARMAN GS AJRAM KA
Citation: Rd. Gingrich et al., A PILOT-STUDY OF AUTOLOGOUS MARROW BLOOD STEM-CELL TRANSPLANTATION INTHE TREATMENT NONMETASTATIC INFLAMMATORY BREAST-CANCER/, Blood, 86(10), 1995, pp. 1529-1529
TOXICITY AND OUTCOME OF A NEW HIGH-DOSE, 4-DRUG ABLATIVE REGIMEN COMBINED WITH AUTOLOGOUS HEMATOPOIETIC STEM-CELL (HSC) RECONSTITUTION FOR PATIENTS WITH STAGE-IV BREAST-CANCER (ST4BC)
Authors: GINGRICH RD LEE CK WEN BC HARMAN GS AJRAM KA
Citation: Rd. Gingrich et al., TOXICITY AND OUTCOME OF A NEW HIGH-DOSE, 4-DRUG ABLATIVE REGIMEN COMBINED WITH AUTOLOGOUS HEMATOPOIETIC STEM-CELL (HSC) RECONSTITUTION FOR PATIENTS WITH STAGE-IV BREAST-CANCER (ST4BC), Blood, 86(10), 1995, pp. 1530-1530
EFFECTS OF T-CELL DOSE AND GVHD ON IMMUNE RECONSTITUTION IN CD2 T-CELL DEPLETION AND 2-LEVEL ADD-BACK (TCD-AB) IN ALLOGENEIC BONE-MARROW TRANSPLANTATION
Authors: LEE CK HARMAN GS HOHL RJ AJRAM KA GINGRICH RD
Citation: Ck. Lee et al., EFFECTS OF T-CELL DOSE AND GVHD ON IMMUNE RECONSTITUTION IN CD2 T-CELL DEPLETION AND 2-LEVEL ADD-BACK (TCD-AB) IN ALLOGENEIC BONE-MARROW TRANSPLANTATION, Blood, 86(10), 1995, pp. 2268-2268
ANTI-CD2 T-CELL DEPLETION WITH 2-LEVEL T-CELL ADDBACK (TCD-AB) IN ALLOGENEIC BONE-MARROW TRANSPLANTATION (AL-BMT)
Authors: LEE CK HAYASHI M HARMAN GS HOHL RJ AJRAM KA GINGRICH RD
Citation: Ck. Lee et al., ANTI-CD2 T-CELL DEPLETION WITH 2-LEVEL T-CELL ADDBACK (TCD-AB) IN ALLOGENEIC BONE-MARROW TRANSPLANTATION (AL-BMT), Blood, 86(10), 1995, pp. 2269-2269
Risultati: 1-7 |